Dignitana
1.6 SEK +0.31%1 investor is following this company
Dignitana is active in medical technology. The company's main focus is to develop, manufacture, and distribute medical aids that are primarily used as a scalp cooling system in chemotherapy treatment, where the purpose is to eliminate or greatly reduce hair loss. The company operates worldwide. Dignitana was founded in 2007 has its headquarters located in Lund.
Revenue
86.06M
EBIT %
-17.46 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
DIGN
Daily low / high price
1.6 / 1.645
SEK
Market cap
128.87M SEK
Turnover
2.24K SEK
Volume
1.4K
Latest videos
Financial calendar
General meeting
23.05.2024
Interim report
23.05.2024
Interim report
22.08.2024
Interim report
21.11.2024
Annual report
20.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Agartha AB | 29.1 % | 29.1 % |
Swedbank Robur Microcap | 7.7 % | 7.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Notice of Annual General Meeting in Dignitana AB (publ)
Dignitana AB: Dignitana's rights issue is registered - conversion of BTA into shares
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools